September 26, 2016Circulation906 citations
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
◼ angioedema ◼ angiotensin-converting enzyme inhibitors ◼ angiotensin receptor blockers ◼ angiotensin receptor
Cite This Study
Yancy et al. (2016) studied this question. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are key pharmacological therapies updated in the 2016 ACC/AHA/HFSA guidelines for the management of heart failure.